Olanzapine
Back to searchMolecule Structure
Scientific Name
Olanzapine
Description of the Drug
Olanzapine is an antipsychotic drug used in the management of schizophrenia, bipolar 1 disorder, and agitation associated with these disorders.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00334
http://www.drugbank.ca/drugs/DB00334
Brand Name(s)
Arkolamyl, Olanzapine, Zalasta, Zyprexa, Zyprexa zydis
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Alkem Laboratories Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Eli Lilly Co, American Regent Inc, Mylan Pharmaceuticals Inc, Hec Pharm Usa Inc, Zydus Pharmaceuticals Usa Inc, Torrent Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
| Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Clinical Trial(s)
Unichem Links
| Atlas | olanzapine | ||||
| SureChEMBL | SCHEMBL28763 | ||||
| Human Metabolome Database | HMDB0005012 | ||||
| DrugBank | DB00334 | ||||
| PubChem: Thomson Pharma | 14923451 | ||||
| PubChem | 135398745 | ||||
| NMRShiftDB | 10021706 | ||||
| LINCS | LSM-5359 | ||||
| Nikkaji | J489.991A | ||||
| BindingDB | 35254 | ||||
| EPA CompTox Dashboard | DTXSID9023388 | ||||
| DrugCentral | 1982 | ||||
| Brenda | 7606 | ||||
| ChemicalBook | CB04188690 | CB6755515 | CB34188691 | CB64188692 | CB52743465 |
| rxnorm | OLANZAPINE PAMOATE MONOHYDRATE | OLANZAPINE | OLANZAPINE PAMOATE | ZYPREXA | |
| PubChem: Drugs of the Future | 12014657 | ||||
| KEGG Ligand | C07322 | ||||
| ChEBI | 7735 | ||||
| ZINC | ZINC000052957434 |
